Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Obesity, Medicaid and Biden
Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity medications. But it's not clear if the proposed change will go into effect.
Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Biden to require Medicare and Medicaid to cover weight loss drugs
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and Medicaid. The move could potentially help some seven million Americans pay for the expensive drugs,
6d
on MSN
New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows
The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...
6d
What's Next for Amgen Obesity Drug After Investors Disappointed by Results
Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.
MarketWatch
21h
Health Care Flat on Mixed Obesity-Drug Fortunes - Health Care Roundup
Recent data from an Amgen
obesity
-
drug
trial only reinforced investors' impressions that Eli Lilly and Novo Nordisk have a prohibitive head start, thanks, in particular, to a new generation of ...
Lohud.com, Westchester County on MSN
10h
We revealed weight-loss drug inequality in New York. Here's why your stories matter
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.
BioPharma Dive
7d
Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark
Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential ...
health.wusf.usf.edu
1d
Dizzy after one drink? Social drinkers on obesity drugs lose the taste for alcohol
A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...
4d
on MSN
Amgen Obesity Drug More Effective Than Competitors
A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.
Wall Street Journal on MSN
7d
Amgen Obesity Drug Cut Weight In Closely Watched Study
A highly anticipated
obesity
-
drug
candidate from biotech Amgen helped patients shed a significant amount of weight in a ...
6d
Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
FiercePharma
1d
Race is on for oral obesity drugs with multiple phase 3 trials vying for next-gen status in a $126B market
Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback